PharmaCyte Biotech, Inc. SEC filings PMCB

PharmaCyte Biotech, Inc. has 472 filings in SEC EDGAR's recent list, going back to Aug 20, 2001. Its latest annual report, Form 10-K, was filed on Jul 29, 2026 for the period ended Apr 30, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 14, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (auditor change). The company's fiscal year ends on April 30.

Form Description Filed Period
10-K Annual report Jul 29, 2026 Apr 30, 2026
ARS Annual report to shareholders Mar 9, 2026 Apr 30, 2025
10-K Annual report Aug 11, 2025 Apr 30, 2025
ARS Annual report to shareholders Mar 10, 2025 Apr 30, 2024
10-K Annual report Aug 13, 2024 Apr 30, 2024
ARS Annual report to shareholders Mar 27, 2024 Dec 31, 2023
10-K Annual report Jul 31, 2023 Apr 30, 2023
10-K Annual report Jul 28, 2022 Apr 30, 2022
10-K Annual report Aug 10, 2021 Apr 30, 2021
10-K Annual report Aug 13, 2020 Apr 30, 2020
10-K Annual report Aug 13, 2019 Apr 30, 2019
10-K Annual report Jul 20, 2018 Apr 30, 2018
10-K Annual report Jul 27, 2017 Apr 30, 2017
10-K Annual report Jul 29, 2016 Apr 30, 2016
10-K/A Amended annual report Mar 2, 2016 Apr 30, 2015
10-K/A Amended annual report Jan 19, 2016 Apr 30, 2015
10-K/A Amended annual report Jan 19, 2016 Apr 30, 2015
10-K Annual report Jul 29, 2015 Apr 30, 2015
10-K/A Amended annual report Oct 17, 2014 Apr 30, 2014
10-K/A Amended annual report Oct 17, 2014 Apr 30, 2013
10-K Annual report Aug 4, 2014 Apr 30, 2014
10-K/A Amended annual report Jul 30, 2013 Apr 30, 2013
10-K Annual report Jul 29, 2013 Apr 30, 2013
10-K Annual report Aug 14, 2012 Apr 30, 2012
10-K Annual report Aug 15, 2011 Apr 30, 2011
10-K/A Amended annual report Apr 26, 2011 Apr 30, 2010
10-K Annual report Dec 29, 2010 Apr 30, 2010
10-K Annual report Aug 13, 2009 Apr 30, 2009

Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
PMCB (Nasdaq)
Fiscal year ends
April 30
Incorporated in
NV
Headquarters
Las Vegas, NV
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1157075
Former names
NUVILEX, INC. (until Jan 9, 2015); EFOODSAFETY COM INC (until Mar 17, 2009)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.